Brookstone Capital Management - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
Brookstone Capital Management ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,134,412
+1.2%
11,987
+1.3%
0.02%
+8.7%
Q2 2023$1,120,618
-33.6%
11,830
-31.4%
0.02%
-30.3%
Q1 2023$1,688,862
-0.0%
17,239
-5.8%
0.03%
-2.9%
Q4 2022$1,689,222
+22.1%
18,303
-0.4%
0.03%
+6.2%
Q3 2022$1,383,000
-11.2%
18,369
-0.5%
0.03%
-5.9%
Q2 2022$1,558,000
+45.1%
18,467
+61.2%
0.03%
+61.9%
Q1 2022$1,074,000
+0.7%
11,454
-4.1%
0.02%
+16.7%
Q4 2021$1,067,000
+24.2%
11,943
+14.7%
0.02%
+20.0%
Q3 2021$859,000
-8.9%
10,416
+2.4%
0.02%
-11.8%
Q2 2021$943,000
+36.5%
10,174
+25.9%
0.02%
-34.6%
Q1 2021$691,000
-8.1%
8,083
+1.5%
0.03%
-13.3%
Q4 2020$752,000
+7.4%
7,966
-1.0%
0.03%
-6.2%
Q3 2020$700,000
-5.8%
8,049
-5.4%
0.03%
-30.4%
Q2 2020$743,000
+230.2%
8,508
+211.6%
0.05%
+253.8%
Q1 2020$225,000
-15.7%
2,730
-3.1%
0.01%
-7.1%
Q4 2019$267,000
+26.5%
2,818
+15.8%
0.01%
+27.3%
Q3 2019$211,000
-10.2%
2,434
-5.5%
0.01%
-21.4%
Q2 2019$235,000
+6.8%
2,576
+12.7%
0.01%0.0%
Q1 2019$220,000
+0.9%
2,285
-10.1%
0.01%
-17.6%
Q4 2018$218,000
+5.3%
2,542
-0.7%
0.02%
-10.5%
Q1 2018$207,000
-9.6%
2,560
-6.0%
0.02%
-9.5%
Q4 2017$229,000
-11.2%
2,724
-9.3%
0.02%
-8.7%
Q3 2017$258,000
+5.3%
3,004
+2.5%
0.02%0.0%
Q2 2017$245,000
+14.0%
2,930
+1.1%
0.02%
+4.5%
Q1 2017$215,000
-2.3%
2,899
-4.1%
0.02%
-8.3%
Q4 2016$220,000
-12.7%
3,023
-5.2%
0.02%
-14.3%
Q3 2016$252,000
-5.3%
3,189
-1.1%
0.03%
-20.0%
Q2 2016$266,000
+28.5%
3,226
+13.4%
0.04%
+12.9%
Q1 2016$207,000
-34.7%
2,844
-22.8%
0.03%
-49.2%
Q4 2015$317,000
-0.9%
3,684
+5.8%
0.06%
+5.2%
Q3 2015$320,000
-37.6%
3,481
-33.3%
0.06%
-10.8%
Q2 2015$513,000
-23.4%
5,217
-23.2%
0.06%
-35.6%
Q1 2015$670,000
+65.4%
6,792
+55.4%
0.10%
+50.7%
Q4 2014$405,000
+24.2%
4,371
+26.3%
0.07%
+9.8%
Q3 2014$326,000
+22.6%
3,461
+17.7%
0.06%
+13.0%
Q2 2014$266,0002,9410.05%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders